Dongping Wei
Overview
Explore the profile of Dongping Wei including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
829
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xu J, Peng P, Wei D, Deng Z
PLoS One
. 2024 Oct;
19(10):e0310112.
PMID: 39405294
Visitor education plays a crucial role in the knowledge diffusion process in outdoor recreation and nature-based tourism. It entails sharing information, experiences, and insights with visitors to enhance their understanding...
2.
Sun Y, Xu J, Wei D, Li H
MedComm (2020)
. 2024 Jul;
5(8):e648.
PMID: 39021515
No abstract available.
3.
Lu Y, Zhao X, Yuan M, Zhao M, Liu K, Zhang M, et al.
J Cancer
. 2024 Apr;
15(9):2475-2485.
PMID: 38577600
Chemotherapy resistance is a barrier to effective cancer prognoses. Cisplatin (CDDP) resistance is a major challenge for esophageal cancer (EC) therapy. A deeper understanding of the fundamental mechanisms of cisplatin...
4.
Liu L, Chen X, Wu L, Huang K, Wang Z, Zheng Y, et al.
Exp Hematol Oncol
. 2024 Mar;
13(1):32.
PMID: 38486234
Background: The evolutionarily conserved protein FBXO9 acts as a substrate receptor for the SKP1-cullin-1-RBX1 ubiquitin ligase and is implicated in cancer, exhibiting either tumor-suppressive or oncogenic effects depending on the...
5.
Zheng Y, Zhang Z, Li X, Wu L, Liu X, Liu L, et al.
Front Biosci (Landmark Ed)
. 2023 Nov;
28(10):257.
PMID: 37919058
Background: Lung adenocarcinoma (LUAD) is one of the most common and lethal cancer types worldwide. LINC0572 is a long non-coding RNA (lncRNA) that has been associated with the clinical characteristics...
6.
Yang Y, Zhu Y, Zhou S, Tang P, Xu R, Zhang Y, et al.
EMBO J
. 2022 Jun;
41(14):e109777.
PMID: 35670107
Autophagy represents a fundamental mechanism for maintaining cell survival and tissue homeostasis in response to physiological and pathological stress. Autophagy initiation converges on the FIP200-ATG13-ULK1 complex wherein the serine/threonine kinase...
7.
Zhang C, Shen L, Zhu Y, Xu R, Deng Z, Liu X, et al.
Theranostics
. 2021 Jan;
11(6):2691-2705.
PMID: 33456567
Despite landmark therapy of chronic myelogenous leukemia (CML) with tyrosine kinase inhibitors (TKIs), drug resistance remains problematic. Cancer pathogenesis involves epigenetic dysregulation and in particular, histone lysine demethylases (KDMs) have...
8.
Zhang Y, Xu B, Shi J, Li J, Lu X, Xu L, et al.
Cell Oncol (Dordr)
. 2020 Oct;
43(6):1049-1066.
PMID: 33006750
Purpose: Stemming from a myriad of genetic and epigenetic alterations, triple-negative breast cancer (TNBC) is tied to poor clinical outcomes and aspires for individualized therapies. Here we investigated the therapeutic...
9.
Shu Z, Li Z, Huang H, Chen Y, Fan J, Yu L, et al.
Oncogene
. 2020 Jul;
39(35):5721-5733.
PMID: 32712628
Ribonucleotide reductase (RNR) catalyzes the rate-limiting step of de novo synthesis of deoxyribonucleotide triphosphates (dNTPs) building blocks for DNA synthesis, and is a well-recognized target for cancer therapy. RNR is...
10.
Zhang P, Zheng Z, Yang X, Zhang Y, Hu G, Wang R, et al.
Future Med Chem
. 2020 Jul;
12(15):1399-1414.
PMID: 32705902
To clarify the molecular mechanism of novel 2-aminonicotinonitrile autophagy enhancers, two series of novel 2-aminonicotinonitrile derivatives are synthesized and their structure-activity relationship and biological activity were analyzed. Structure-activity relationship analysis...